Consistently, heterozygous R882 mutations in normal karyotype AML patients are associated with a more pronounced reduction of DNA methylation than the rest of DNMT3A mutations40, and R882H mutation in individuals with clonal hematopoiesis similarly led to DNA hypomethylation at selective loci41. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.